About
RegenLab Global, based in Le Mont-sur-Lausanne, Switzerland, is a leader in autologous regenerative medicine. Founded in 2003, the company specializes in Platelet-Rich Plasma (PRP) therapies derived from patients' own blood. RegenLab develops high-quality medical devices and cell therapy products aimed at enhancing healing across various therapeutic areas, including musculoskeletal disorders, dermatology, wound care, and intimate health. The company operates GMP-certified facilities in Switzerland, New York, and France, ensuring compliance with ISO 13485 and CE standards, as well as approvals from regulatory bodies like the FDA. Its product line, primarily marketed under the RegenKit brand, includes PRP preparation kits and combined therapies. RegenLab's innovations have benefited over 2 million patients in more than 160 countries, reflecting its strong global presence and commitment to advancing regenerative medicine through extensive research and development.
Keywords
Company Information
-
Employees 110
-
Founded 2003
Location
Chemin de Budron B, Le Mont-sur-Lausanne, Vaud, Switzerland, 1052
